Skip to main content

Table 1 Comparison of patient characteristics between males and females

From: Sex difference in the risk of extubation failure in ICUs

 

Male (n = 425)

Female (n = 216)

P value*

Characteristics of the patients at admission

  

0.381

 Age, years

69 ± 10

70 ± 11

0.164

 Age > 65 years, n (%)

298 (70%)

162 (75%)

0.194

 Body-mass index, kg/m2

28 ± 6

29 ± 8

0.001

 Body-mass index ≥ 30 kg/m2, n (%)

121 (29%)

85 (41%)

0.004

 SAPS II at admission, points

55 ± 18

56 ± 19

0.494

 Underlying chronic cardiac disease, n (%)

218 (51)

88 (41%)

0.011

  Ischemic heart disease

129 (30%)

37 (17%)

 < 0.001

  Atrial fibrillation

66 (15%)

37 (17%)

0.602

  Left ventricular dysfunction

61 (14%)

30 (14%)

0.873

  History of cardiogenic pulmonary edema

31 (7%)

15 (7%)

0.871

 Underlying chronic lung disease, n (%)

143 (34%)

70 (32%)

0.752

  Chronic obstructive pulmonary disease

109 (26%)

41 (19%)

0.059

  Obesity-hypoventilation syndrome

25 (6%)

24 (11%)

0.018

  Chronic restrictive pulmonary disease

25 (6%)

11 (5%)

0.681

Main reason for admission, No. (%)

  

0.026

 Acute respiratory failure

202 (47%)

113 (52%)

0.251

 Coma

41 (10%)

34 (16%)

0.023

 Shock

48 (11%)

15 (7%)

0.080

 Cardiac arrest

48 (11%)

13 (6%)

0.031

 Surgery

41 (10%)

22 (10%)

0.828

 Other reason

45 (11%)

19 (9%)

0.474

Characteristics of the patients on the day of extubation

 SOFA score, points

4.4 ± 2.7

4.0 ± 2.5

0.051

 Duration of mechanical ventilation, days

6 [3–10]

5 [3–10]

0.901

 Difficult or prolonged weaning #, n (%)

133 (31%)

73 (34%)

0.521

 Ineffective cough, n/n total (%)

95/400 (24%)

56/206 (27%)

0.354

 Abundant secretions, n/n total (%)

170/406 (42%)

65/208 (31%)

0.010

 Administration of steroids before extubation, n (%)

66 (15%)

29 (13%)

0.478

Ventilatory settings before the spontaneous breathing trial

 Pressure-support ventilation, n (%)

369 (87%)

179 (83%)

0.197

 Pressure-support level, cm H2O

9.3 ± 2.7

9.9 ± 3.1

0.019

 Positive end-expiratory pressure, cm H2O

5.7 ± 1.6

6.0 ± 1.5

0.042

 Respiratory rate, breaths/min

22 ± 6

23 ± 7

0.007

 Tidal volume, ml

505 ± 140

413 ± 102

< 0.001

 Tidal volume, ml/kg of predicted body weight

7.5 ± 2.2

8.1 ± 2.3

0.005

 Rapid shallow breathing index: F/VT, breaths/min/l

48 ± 26

60 ± 26

< 0.001

 FiO2, %

35 ± 11

35 ± 10

0.949

 PaO2/FiO2, mm Hg

277 ± 91

268 ± 90

0.215

 pH, units

7.45 ± 0.06

7.45 ± 0.06

0.501

 PaCO2, mm Hg

39 ± 7

40 ± 9

0.153

 PaCO2 > 45 mm Hg, No. (%)

78 (18%)

44 (20%)

0.467

Characteristics of the spontaneous breathing trial

 Type of trial

  T-piece trial, n (%)

262 (62%)

132 (61%)

0.895

  Low level of pressure-support, n (%)

163 (38%)

84 (39%)

 Median duration of the trial, min

60 [30–60]

60 [30–60]

0.916

Respiratory support after extubation

 Prophylactic noninvasive ventilation, n (%)

230 (54%)

109 (50%)

0.381

 High-flow nasal oxygen, n (%)

195 (46%)

107 (50%)

  1. Continuous variables are given in mean ± standard deviation or median [interquartile range, IQR 25th – 75th percentiles] according to their distribution
  2. * In bold all variables significantly different between males and females with a p value of less than 0.05 are indicated
  3. Abbreviations: SAPS = Simplified Acute Physiology Score; SOFA = Sepsis-related Organ Failure Assessment; SBT = Spontaneous Breathing Trial; F/VT = rapid shallow breathing index calculated as the ratio of respiratory frequency (F) divided by tidal volume (VT)
  4. # Difficult or prolonged weaning refers to patient who failed the first spontaneous breathing trial and were not extubated the day of the first trial